Abeona Therapeutics Inc
F:PCJP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abeona Therapeutics Inc
F:PCJP
|
US |
|
Publicis Groupe SA
F:PU41
|
FR |
|
Toyota Motor Corp
F:TOM
|
JP |
|
A
|
Adevinta ASA
OTC:ADEVF
|
NO |
|
A
|
AXA SA
XMUN:AXA
|
FR |
|
G
|
Grandvision NV
F:8GV
|
NL |
|
F
|
Factset Research Systems Inc
XMUN:FA1
|
US |
|
Novartis AG
F:NOT
|
CH |
|
E
|
Exxaro Resources Ltd
XMUN:LCQ
|
ZA |
|
M
|
Melco Resorts & Entertainment Ltd
SWB:MAS
|
HK |
|
Investec Ltd
OTC:ITCFY
|
ZA |
Wall St Price Targets
PCJP Price Targets Summary
Abeona Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for PCJP is 0.4104 EUR with a low forecast of 0.2886 EUR and a high forecast of 0.6001 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PCJP's stock price target?
Price Target
0.4104
EUR
According to Wall Street analysts, the average 1-year price target for PCJP is 0.4104 EUR with a low forecast of 0.2886 EUR and a high forecast of 0.6001 EUR.
What is the Revenue forecast for Abeona Therapeutics Inc?
Projected CAGR
233%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 233%.
What is the Gross Profit forecast for Abeona Therapeutics Inc?
Projected CAGR
280%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 280%.
What is the Pre-Tax Income forecast for Abeona Therapeutics Inc?
Projected CAGR
-22%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -22%.
What is the Net Income forecast for Abeona Therapeutics Inc?
Projected CAGR
-20%
The compound annual growth rate for Net Income over the next 3 years is -20%.
